Criteria for selecting patients with resistant hypertension for a renal sympathetic denervation
- Authors: Ripp TM1, Rebrova TY.1, Mordovin VF1, Afanasiev SA1, Pekarsky SE1, Semke GV1, Falkovskaya AY.1, Lichikaki VA1, Tsymbalyuk EV1
-
Affiliations:
- НИИ кардиологии
- Issue: Vol 88, No 8 (2016)
- Pages: 14-18
- Section: Editorial
- URL: https://journals.rcsi.science/0040-3660/article/view/32035
- DOI: https://doi.org/10.17116/terarkh201688814-18
- ID: 32035
Cite item
Full Text
Abstract
About the authors
T M Ripp
НИИ кардиологииТомск, Россия
T Yu Rebrova
НИИ кардиологииТомск, Россия
V F Mordovin
НИИ кардиологииТомск, Россия
S A Afanasiev
НИИ кардиологииТомск, Россия
S E Pekarsky
НИИ кардиологииТомск, Россия
G V Semke
НИИ кардиологииТомск, Россия
A Yu Falkovskaya
НИИ кардиологииТомск, Россия
V A Lichikaki
НИИ кардиологииТомск, Россия
E V Tsymbalyuk
НИИ кардиологииТомск, Россия
References
- Mancia G, Fagard R, Narkiewicz K et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension. J Hypertens. 2013;31(7):1295-1297. doi: 10.1016/j.rec.2013.07.015
- Mancia G, Laurent S, Agabiti-Rosei E at al. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens. 2009;27:2121-2158. doi:10.3109/ 08037050903 450468
- Urban D, Ewen S, Ukena C, et al. Treating resistant hypertension: role of renal denervation. Integr Blood Press Control. 2013;11(6):119-128. doi: 10.2147/ibpc.s33958
- Calhoun DA, Jones D, Textor S et al; American Heart Association Professional Education Committee. Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Circulation. 2008;117(25):510-526. doi: 10.1161/hypertensionaha.108.189141
- Daugherty SL, Powers JD, Magid DJ et al. Resistant hypertension. Incidence and prognosis of resistant hypertension in hypertensive patients. J Circulation. 2012;125(13):1635-1642. doi: 10.1161/circulationaha.111.068064
- Grassi G. Assessment of sympathetic cardiovascular drive in human hypertension: achievements and perspectives. J Hypertens. 2009;54(4):690-697. doi: 10.1161/hypertensionaha.108.119883
- Mancia G, Grassi G, Giannattasio C et al. Sympathetic activation in the pathogenesis of hypertension and progression of organ damage. J Hypertens. 1999;34:724-728. doi: 10.1161/01.hyp.34.4.724
- Стрюк Р.И., Длусская И.Г. Адренореактивность и сердечно-сосудистая система. М.; 2003.
- Бунова С.С., Остапенко В.А., Николаев Н.А., Нелидова А.В., Кузюкова А.А., Трошкина Т.Г., Москвина. Артериальная гипертония и адренореактивность: особенности у больных с ожирением. Бюллетень СО РАМН. 2008;1(129):77-81.
- Krum H, Barman N, Schlaich M et al. Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months. J Hypertensn. 2011;57 (5):911-917. doi: 10.1161/hypertensionaha.110.163014
- Esler MD, Krum H, Sobotka PA et al. Renal sympathetic denervation in patients with treatment-resistant hypertension (the Symplicity HTN-2 trial): a randomized controlled trial. J Lancet. 2010;376:1903-1609. doi: 10.1016/s0140-6736(10)62039-9
- Mahfoud F, Linz D, Mancia G et al. Renal artery denervation for treatment of hypertensive patients with or without obstructive sleep apnea and resistant hypertension: results from the global symplicity registry. J Hypertens. 2015;33(Suppl 1):e108.
- Briasoulis A, Bakris G. Renal Denervation After SYMPLICITY HTN-3: Where Do We Go? Can J Cardiol. 2015;31(5):642-648. doi: 10.1016/j.cjca.2014.12.004
- Sapoval M, Azizi M. Renal artery denervation for the treatment of resistant hypertension. Update after Medtronic announcement that its Symplicity HTN3 study failed to meet its primary efficacy end point. Diagn Interv Imag. 2014;95(4):353-354. doi: 10.1016/j.diii.2014.02.022
- Bauer A et al. A scoring system for identification of responders to renal sympathetic denervation. Eur Heart J. 2014;35:1190.
- Рипп Т.М., Мордовин В.Ф., Пекарский С.Е. и совт. Кардиопротективные возможности денервации почек при лечении резистентной гипертонии, поиск предикторов эффективности. Артериальная гипертензия. 2014;20(6):28-133. doi: 10.1097/01.hjh.0000468497.97663.2a
![](/img/style/loading.gif)